Myoclonin-1: Potential Drug Target and Biomarker (G114327)

Target Name: EFHC1

NCBI ID: G114327

EFHC1

Myoclonin-1: Potential Drug Target and Biomarker

Myoclonin-1 (EFHC1) is a protein that is expressed in muscle cells and is known for its role in the regulation of muscle growth and function. It is a key regulator of the myofibrosis process, which is the process by which muscle cells rebuild and repair themselves following injury or overuse. Myoclonin-1 has also been shown to play a role in the development of certain diseases, such as heart failure and cancer.

Despite the promising potential of myoclonin-1 as a drug target, much work remains to be done before it can be safely and effectively used in humans. In this article, we will explore the biology and function of myoclonin-1, as well as its potential as a drug target and biomarker.

Biology and Function of Myoclonin-1

Myoclonin-1 is a 21-kDa protein that is expressed in muscle cells and secreted into the interstitial fluid. It is one of a family of proteins known as myoclons, which are involved in the regulation of muscle growth and function. Myoclonin-1 is composed of a unique transmembrane domain that is involved in its localization to the muscle plasma membrane, as well as a cytoplasmic tail that is involved in its stability and interactions with other proteins.

Myoclonin-1 plays a key role in the regulation of muscle growth and function. It is involved in the formation of myofibrils, which are the basic units of muscle tissue, and in the regulation of the myofibrillar cytoskeleton. Myoclonin-1 is also involved in the regulation of muscle protein synthesis and degradation, as well as in the regulation of muscle cell apoptosis.

In addition to its role in muscle biology, myoclonin-1 has also been shown to play a role in the development and progression of certain diseases. For example, myoclonin-1 has been shown to be involved in the development of certain types of cancer, such as muscle cancer and myocardial cancer. It has also been shown to be involved in the development of heart failure, a condition that is characterized by the inability of the heart to pump enough blood to meet the needs of the body.

Potential as a Drug Target and Biomarker

Despite the promising potential of myoclonin-1 as a drug target and biomarker, much work remains to be done before it can be safely and effectively used in humans. One of the main challenges in studying myoclonin-1 as a drug target is its complex biochemical and cellular mechanisms of action. In order to effectively target myoclonin-1 with drugs, it is important to have a thorough understanding of its biology and function.

Another challenge is the development of myoclonin-1-based biomarkers for diagnostic and therapeutic applications. In order to use myoclonin-1 as a biomarker, it is important to have methods for its detection and quantification in analytical techniques for biological specimens, such as mass spectrometry, Western blotting, qPCR, ELISA, immunofluorescence staining technology, etc. It is difficult for the test kits currently on the market to meet these needs. In addition, because the content of Myoclonin-1 in the body is extremely low, its possibility as a drug target is also limited.

Conclusion

In conclusion, myoclonin-1 is a protein that is expressed in muscle cells and is involved in the regulation of muscle growth and function. It has also been shown to play a role in the development and progression of certain diseases. Despite the promising potential of myoclonin-1 as a drug target and biomarker, much work remains to be done before it can be safely and effectively used in humans. Further research is needed to better understand its biology and function, as well as develop methods for its detection and quantification in Analytical techniques for biological specimens.

Protein Name: EF-hand Domain Containing 1

Functions: Microtubule-associated protein which regulates cell division and neuronal migration during cortical development. Necessary for mitotic spindle organization (PubMed:19734894, PubMed:28370826). Necessary for radial and tangential cell migration during brain development, possibly acting as a regulator of cell morphology and process formation during migration (PubMed:22926142). May enhance calcium influx through CACNA1E and stimulate programmed cell death (PubMed:15258581). Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating (By similarity)

The "EFHC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EFHC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets